Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2021 Feb 18;15(2):e0009138. doi: 10.1371/journal.pntd.0009138

Malaria and helminth co-infections in children living in endemic countries: A systematic review with meta-analysis

Muhammed O Afolabi 1,*, Boni M Ale 2, Edgard D Dabira 3, Schadrac C Agbla 4, Amaya L Bustinduy 5, Jean Louis A Ndiaye 6,7, Brian Greenwood 1
Editor: Jessica K Fairley8
PMCID: PMC7924789  PMID: 33600494

Abstract

Background

Current knowledge on the burden of, and interactions between malaria and helminth co-infections, as well as the impact of the dual infections on anaemia, remains inconclusive. We have conducted a systematic review with meta-analysis to update current knowledge as a first step towards developing and deploying coordinated approaches to the control and, ultimately, elimination of malaria-helminth co-infections among children living in endemic countries.

Methodology/Principal findings

We searched Medline, Embase, Global Health and Web of Science from each database inception until 16 March 2020, for peer-reviewed articles reporting malaria-helminth co-infections in children living in endemic countries. No language restriction was applied. Following removal of duplicates, two reviewers independently screened the studies for eligibility. We used the summary odds ratio (OR) and 95% confidence intervals (CI) as a measure of association (random-effects model). We also performed Chi-square heterogeneity test based on Cochrane’s Q and evaluated the severity of heterogeneity using I2 statistics. The included studies were examined for publication bias using a funnel plot and statistical significance was assessed using Egger’s test (bias if p<0.1).

Fifty-five of the 3,507 citations screened were eligible, 28 of which had sufficient data for meta-analysis. The 28 studies enrolled 22, 114 children in 13 countries across sub-Saharan Africa, Southeast Asia and South America. Overall, the pooled estimates showed a prevalence of Plasmodium-helminth co-infections of 17.7% (95% CI 12.7–23.2%). Summary estimates from 14 studies showed a lower odds of P. falciparum infection in children co-infected with Schistosoma spp (OR: 0.65; 95%CI: 0.37–1.16). Similar lower odds of P. falciparum infection were observed from the summary estimates of 24 studies in children co-infected with soil transmitted helminths (STH) (OR: 0.42; 95%CI: 0.28–0.64).

When adjusted for age, gender, socio-economic status, nutritional status and geographic location of the children, the risk of P. falciparum infection in children co-infected with STH was higher compared with children who did not have STH infection (OR = 1.3; 95% CI 1.03–1.65).

A subset of 16 studies showed that the odds of anaemia were higher in children co-infected with Plasmodium and STH than in children with Plasmodium infection alone (OR = 1.20; 95% CI: 0.59–2.45), and were almost equal in children co-infected with Plasmodium-Schistosoma spp or Plasmodium infection alone (OR = 0.97, 95% CI: 0.30–3.14).

Conclusions/Significance

The current review suggests that prevalence of malaria-helminth co-infection is high in children living in endemic countries. The nature of the interactions between malaria and helminth infection and the impact of the co-infection on anaemia remain inconclusive and may be modulated by the immune responses of the affected children.

Author summary

Updated evidence is needed to guide the planning and implementation of appropriate interventions for control of mixed infections involving malaria and worms affecting children living in endemic countries. We performed a systematic review and meta-analysis to update current knowledge on the magnitude of the burden of dual infections with malaria and worms in children in the developing world. We searched all published articles available in Medline, Embase, Global Health and Web of Science from the database inception until 16 March 2020, without any language restriction. We found 55 eligible studies, and 28 of these studies were included in the meta-analysis. A summary of the evidence synthesis showed that the burden of dual infections involving malaria and worm parasites is high in children and varies significantly across endemic countries. There was a lower risk of P. falciparum infection in children infected with soil transmitted helminths (STH) or S. haematobium or S.mansoni. Conversely, the odds of anaemia were higher in children who had dual infections with Plasmodium and STH parasites than in children with a Plasmodium infection alone while the odds of anaemia were almost equal in children who were co-infected with Plasmodium-Schistosoma compared to those with a Plasmodium infection alone. These findings underscore the need to further understand the epidemiology of malaria-helminth co-infections in order to support implementation of appropriate interventions for control and, ultimately, elimination of the dual infections in children living in endemic countries, especially low and middle-income countries (LMIC).

Introduction

Multi-parasitism, also described as polyparasitism, is the concomitant occurrence of two or more parasite species in a single human host [1]. The parasite species broadly categorised into two groups are macroparasites and microparasites. While macroparasites comprise parasitic helminths (nematodes and trematodes); microparasites affecting humans are mainly protozoa. Descriptive studies have shown that parasitic helminths (macroparasites) such as soil transmitted helminths (STH) and Schistosomes, may co-exist with Plasmodium protozoa (microparasites) in children living in resource-poor settings of the world [24].

A recent WHO report showed that an estimated 228 million cases of malaria occurred globally, with sub-Saharan Africa (SSA) and Southeast Asia accounting for about 97% of the burden [5]. Plasmodium falciparum remains the most prevalent malaria parasite in the WHO African Region, causing 99.7% of the estimated malaria cases in 2018, and 50% in the WHO Southeast Asia Region. Globally, children aged less than five years are the most vulnerable group affected by malaria. In 2018, they accounted for 67% (272 000) of all malaria deaths worldwide [5].

Adding to this very high burden of malaria is the frequent co-existence of parasitic helminths among children living in low and middle-income countries (LMIC) [2]. It is estimated that 1.5 billion individuals are infected with helminths [6], with more than 800 million children in LMIC affected by STH primarily hookworm (Ancylostoma duodenale and Necator americanus), roundworm (Ascaris lumbricoides), and whipworm (Trichuris trichiura) [7]. Other important helminths that may co-exist with malaria in children in LMIC include Schistosoma haematobium and S. mansoni [8].

Schistosomiasis and STH account for a global burden of over 5.2 and 3.3 million disability-adjusted life years, respectively [6] and are associated with anaemia [9, 10], malnutrition [3, 11], and impaired physical and cognitive development [1214] among preschool-aged children and school-aged children.

An interplay of environmental and host factors has been implicated in favouring mixed infections of parasitic helminths (STH and Schistosoma species) with malaria species [15, 16]. Statistical and spatial models also support the geographic overlap and co-endemicity of falciparum malaria and hookworm infections in SSA, suggesting that about 25% of school-aged children are at risk of these two groups of infection [2]. Similar spatial distribution has been documented for the association between malaria and schistosomiasis [11].

This overlap in the endemicity of intestinal helminths and malaria parasites is recognised to be responsible for a high prevalence of malaria-helminth co-infections, with synergistic and antagonistic interactions between helminth and malaria parasites [1618]. There is some evidence that infections with Schistosomes and STH also exert deleterious effects on the course and outcome of clinical malaria [2, 17]. Prominent among the clinical outcomes of malaria-helminth co-infections among children living in LMIC is anaemia [9, 10]. Consequently, in endemic countries where malaria and helminths co-exist, there is potential for these infections to act together to worsen anaemia, a situation previously described as a ‘perfect storm of anaemia’ [9].

Despite the obvious effects of malaria-helminth co-infections, the nature of the interactions between the two parasites is not clear; existing studies report conflicting findings on the association between malaria and helminths. This may be due to the complexity of multiple pathways involved in the interactions between malaria and helminth parasites during the co-infection [16]. While some studies reported protective effect of hookworms and S. haematobium infection against Plasmodium infection [4, 19], other reported increased Plasmodium infection in children infected with S. mansoni [17].

In 2016, two systematic reviews [7, 8] were published to address the limitations identified in the findings of previous narrative reviews on malaria-helminth co-infections [18, 20]. Consistent with previous reviews, the 2016 review reported an over-estimation of the evidence of the relationship between malaria and helminth parasites making it difficult to conclusively establish the burden of malaria-helminth dual infections and the contribution of helminths to the interactions in the co-infection [7, 8]. This limitation may be overcome by employing interactive geospatial maps [2123] to generate real-time epidemiological profile of malaria-helminth co-infections among children in LMIC. This approach has the potential to improve the evidence generated from traditional reviews, which are usually undermined by the methodological limitations of the primary studies included in the reviews.

The objective of this study was to systematically review available data on the burden of malaria-helminth co-infections and the nature of interactions between Plasmodium malaria and helminth infections (STH and Schistosoma spp) among children living in endemic countries, with a view to establishing how control of malaria and helminth infections might be better co-ordinated in the future.

Methods

Protocol development and registration

We developed and prospectively registered the study protocol on PROSPERO (https://www.crd.york.ac.uk/PROSPERO/) [CRD42020171095]. The systematic review was conducted according to PRISMA guidelines [24].

Eligibility criteria

The PECO framework [25] was used to aid the selection of published articles relevant to the search terms which were eligible for the review, where ‘P’ stands for the population (children aged 1–16 years living in endemic areas); ‘E’ for exposure (malaria and helminth co-infection); ‘C ‘for comparator which is not applicable in the context of this review; and ‘O’ stands for outcome of interest (anaemia). Epidemiological studies, except case series and case reports, reporting co-infection of P. falciparum and/or P. vivax with STH (Ascaris lumbricoides, hookworm and T. Trichuria) and/or schistosomes (S. haematobium and S.mansoni), in children aged 1–16 years living in endemic countries, were included. Unpublished research theses, conference abstracts, grey literature, and studies conducted outside endemic countries were excluded after screening the titles and abstracts were excluded. Also excluded were studies which enrolled only adults or pregnant women, because pathophysiology and immunological effects of malaria and helminth infections differ significantly in children from adults and pregnant women [26]. Further studies were removed after review of the full papers, if they did not meet the eligibility criteria highlighted above.

Definitions

For the purpose of this review, Plasmodium infection was defined as microscopic confirmation of asexual Plasmodium species with or without clinical features of uncomplicated or severe malaria [27]. P. falciparum and P. vivax density was defined as the number of parasites per microliter of blood. STH and Schistosoma infections were defined by detection of eggs using FLOTAC, urine filtration or Kato-Katz methods [27]. Kato-Katz thick smears were produced from the stool samples collected from the children and these samples were analysed using light microscopy to determine the egg counts for S. mansoni and STH. The numbers of eggs per slide were used to obtain a measure of the number of helminth eggs per gram of faeces (EPG). Anaemia was defined as a haemoglobin concentration below the WHO cut-off values of 11.0 g/dl for children aged 6–59 months; 11.5 g/dl for those 5–11 years; 12.0 g/dl for those 12–14 years [28].

Search strategy

The first author (MOA) searched Medline, Embase, Global Health and Web of Science from each database inception until 16 March 2020, using compound search strategy combining related truncated and non-truncated terms or synonyms tailored to each of the databases. Additional titles and abstracts were obtained through hand search of a list of references of potentially relevant papers. The search was limited to studies conducted in humans, but no language restrictions were applied. The search terms were ‘malaria’ OR ‘Plasmodium’ OR ‘Plasmodium falciparum’ OR ‘Plasmodium vivax’ AND ‘helminth’ OR ‘Soil transmitted helminth’ OR ‘geohelminth’ OR ‘Ascaris lumbricoides’ OR ‘Ascariasis’ AND ‘hookworm’ AND ‘Trichuris trichuria’ AND ‘bilharziasis’ OR ‘Schistosoma’ OR ‘Schistosoma mansoni’ OR ‘Schistosoma haematobium’ AND ‘children’ OR ‘paediatric’ AND ‘developing world’ OR ‘low and mid-income countries’. Details of the complete search strategy are provided in the protocol (S1 File).

After removing duplicates from the search outputs, screening of 133 abstracts was conducted independently for eligibility for full text review by two reviewers (BMA and EDD), using a systematic review app, Rayyan, (https://rayyan.qcri.org/) [29]. Disagreements between the two reviewers on the inclusion of a study for full text review were resolved following discussions with a third independent reviewer.

Data collection

Full text papers for 55 eligible abstracts/titles were retrieved and relevant data were extracted. The following data were extracted: first author and year of publication, country/setting, study title and objectives; confirmation of eligibility for review; methodology—study design, sample size, study duration, data collection with study time points; population of interest; prevalence/incidence and density of Plasmodium and helminth co-infection, prevalence of anaemia; authors key discussions, comments, limitations and reviewers’ comments, where provided.

Quality and bias assessment

To ascertain the internal and external validity of the included studies, the risk of bias and quality of each study were assessed using a combination of Newcastle Ottawa Scale (NOS) [30] and Effective Public Health Practice Project (EPHHP) tools [31], which are recommended for systematic reviews by The Cochrane Public Health Review Group [32]. Eligible studies were assessed from three angles: selection of the study groups, comparability of the study groups, and the ascertainment of the outcome of interest. Based on these criteria, the overall quality of each study was scored as weak, moderate, or strong. In addition, each study was assessed for selection bias, study design, confounding, blinding, data collection methods, and withdrawals and drop-outs.

Data analysis

Given a very high level of heterogeneity between included studies, meta-analysis was possible in only 28 studies. Data synthesis was performed to estimate pooled effect estimates across studies, allowing for between-study heterogeneity. We adopted Odds Ratio (OR) as a measure of association. We extracted from the papers data about adjusted odds ratio (aOR) of asymptomatic/uncomplicated or severe Plasmodium infection and related anaemia along with 95% confidence interval (CI) for children infected with STH or S. haematobium or S. mansoni. We extracted raw data for only malaria positive, only STH-positive, only S. haematobium or S. mansoni-positive, malaria-S. haematobium or S. mansoni-positive, malaria-and STH-positive, and intestinal helminth- and malaria-negative and used these data to estimate the pooled prevalence of malaria in the group of children who were malaria positive and STH/Schistosoma positive compared to the prevalence in those who were malaria positive and STH/Schistosoma negative. We also used the data obtained to calculate the crude odds of asymptomatic/uncomplicated or severe Plasmodium infection and related anaemia in children infected with Schistosomes or STH compared to those infected with Plasmodium parasites only, along with their 95% CI. The log OR and the standard error (SE) of the log OR were estimated using generic inverse variance weighting method [33] and the summary estimate (summary-odds ratio) was estimated. We performed Chi-square heterogeneity test using Cochrane’s Q. Moreover, I2statistic was used to assess the severity of inconsistency (or heterogeneity) across studies. We also examined the studies for publication bias using funnel plots and Egger’s test for correlation between the effect estimates and their variances. We used random effects model to estimate the summary Mantel-Haenszel OR of asymptomatic/uncomplicated or severe Plasmodium infection in children infected with STH or Schistosomes compared to those with Plasmodium infection only. We conducted meta-regression to adjust for confounding variables such as age, gender, socio-economic status and nutrition status of the children, as well as study design and geographic location of the study participants. A sensitivity analysis was conducted to assess the robustness of the pooled summary effects by excluding each of the studies from the pooled estimate. Sub-group analyses by helminth types, geographic region and study design were done to compare pooled estimates of the prevalence of the co-infection. All statistical analyses were performed using R software version 4.0.2, R Project for Statistical Computing (https://www.r-project.org/).

Narrative reviews were conducted for 27 studies which did not contain sufficient data that allowed meta-analysis. We adopted a framework consisting of three elements: (i) developing a preliminary synthesis of findings of included studies; (ii) exploring relationships within and between studies; and (iii) assessing the robustness of the synthesis. Studies were grouped together if they compared similar types of outcomes of interest. Content analysis of emerging themes from each group was performed and the summary is presented.

Results

Search results and characteristics of included studies

As illustrated in Fig 1, 3,057 citations were generated from database searches on Embase (n = 814), Global Health (n = 1,430), Medline (n = 577), Web of Sciences (n = 220) and manual search from reference list of potentially eligible titles (n = 16). A total of 2,924 duplicates were removed in two stages. One hundred and thirty-three abstracts/titles were screened for eligibility, following which a further 78 citations were excluded due to reasons such as wrong outcomes/wrong populations (n = 67), duplicates (n = 3), and the full text not available (n = 8). We contacted the authors of these abstracts to ascertain whether the full text papers were available. One author confirmed that a manuscript for the abstract was under development, but no feedback was received from the other authors. The full text papers of the remaining 55 citations were reviewed, 27 of which contained inadequate data for meta-analysis. Narrative reviews were performed on these 27 studies [19, 3459]; data from the remaining 28 studies [4,14,17,6084] were included in the meta-analysis.

Fig 1. PRISMA flow diagram showing the process undertaken for inclusion and exclusion of studies in the systemic review.

Fig 1

The characteristics of the 55 studies included in the systematic review are summarised in Table 1. A total of 37,559 children were enrolled in the 55 studies conducted across SSA, Southeast Asia and South America. Forty-three of the studies (78.2%) were cross-sectional, five (9.1%) were longitudinal studies, four (7.3%) were randomised controlled trials (RCT), and three (5.4%) were case-control studies. Thirty-seven studies reported P. falciparum and STH co-infection; 23 studied P. falciparum and S. haematobium co-infection; eight studied P.falciparum and S. mansoni co-infection and only two reported P. vivax and STH co-infection.

Table 1. Characteristics of included studies.

SN Author Country/year of study Study design Sample size Age range Co-infection reported Prevalence of co-infection (%) Magnitude of outcomes in Plasmodium-helminth co-infected participants vs those infected with Plasmodium only Overall quality score
1 Achidi et al, 2008 [60] Cameroon
2004–2005
Cross-sectional 263 4–12 years Pf+ STH 65.9
1. Similar Pf prevalence (OR: 1.29; 95% CI 0.60–2.76)
2. Similar Hb levels
Moderate
2 Adedoja et al, 2015 [61] Nigeria 2012–2013 Cross-sectional 1017 4–15 years Pf+ HK
Pf + Sh
29.2
50.7
1.Higher Pf prevalence
2. Similar Pf risk: Children infected with Sh (RR = 1.3, p = 0.04) and HK (RR = 1.4, p = 0.01) have equal chances of being infected with Pf
3. Higher anaemia risk
Strong
3 Doumbo et al, 2014 [67] Mali 2011–2012 Longitudinal cohort 616 3 months—25 years Pf + Sh 8.5 1. Higher Pf prevalence, OR: 3.23; 95%
CI: 1.76, 5.90
2. Similar Pf risk (HR)
3. Heavy Sh negatively associated with Pf density but light Sh not associated with Pf density
Strong
4 Akanni et al, 2014 [34] Nigeria NR Cross-sectional 292 1–15 years Pf + STH
Pf+ Sm
NR Lower mean Hb and serum ferritin levels (p>0.05) Weak
5 Humphries et al, 2013 [36] Ghana
2010
Cross-sectional 812 6–11 years Pf+ HK 35.1 Higher Pf density, with OR for HK infection increasing with higher Pf parasite density (OR = 5.50, 95% CI 2.10, 14.41, P< 0.01) Moderate
6 Humphries et al, 2011 [35] Ghana 2007 Cross-sectional 132 1–15 years Pf + HK 51% in 6–10 year olds 1. Higher Pf prevalence (aOR = 2.84, 95%CI = 1.11, 7.26), with highest prevalence of co-infection (51%) in 6–10 year olds.
2. Similar anaemia risk (aOR = 2.34; 95% CI = 0.56, 9.84, p = 0.25)
Moderate
7 Ajayi et al, 2015 [84] Nigeria 2011 Cross-sectional 370 6 months—14 years Pf+ STH 42.9 1.Risk of Pf +STH co-infection about two times in children aged 5.5–10 years compared to under-fives (OR = 2.3, 95% CI = 0.19, P = 0.95). 2. Similar anaemia risk (P = 0.93) Weak
8 Briand et al, 2005 [37] Senegal 2001–2002 Cross-sectional 523 3–15 years Pf + Sh NR Children lightly infected with Sh had lower Pf densities than non-infected children (β: -0.34, 95%
CI: −0.85, −0.10)
Moderate
9 Burdam et al, 2016 [64] Indonesia 2013 Cross-sectional 533 12–59 months Pf+ STH
Pv + STH
7.1
15.3
1. Higher Plasmodium risk = Pv: OR 3.75 (95%CI, 1.53–9.2), p = 0.004; Pf: OR 2.0 (95%CI, 0.4–10.1), p = 0.402
2. Higher anaemia risk for Pf or Pv + STH (OR 4.0 [95%CI, 1.4–11.3], p = 0.008) and severe anaemia (OR 8.6 [95%CI, 1.3–55.8], p = 0.024).
Moderate
10 Brutus et al, 2006 [38] Madagascar 1996–1997 RCT 350 4–16 years Pf+ Al NR 1. Levamisole treatment effect on Al + Pf = 0.58, 95% CI: 0.10–0.95, p = 0.018
2. Negative interaction between Al and Pf parasite density in children aged ≥5 years
Moderate
11 Brutus et al, 2007 [39] Madagascar 1996–1997 RCT 312 4–16 years Pf+ Al NR 1. Levamisole treatment effect on Al + Pf = 0.58, 95% CI: 0.20–0.95, p = 0.003
2. Negative interaction between Al infection and Pf parasite density in 5–14 year old
Moderate
12 Bwanika et al, 2018 [65] Uganda NR Case-control 240 7.6 ± 3.0 years Pf + STH
Pf+ Al
Pf+ HK
13.3
78.1
21.2
Higher levels of IL-10 (304 pg/ml) expressed compared to Pf only infected children (11.57 pg/ml), P< 0.05 Moderate
13 Carmona_Fonseca et al, 2006 [66] Colombia 2004–2005 Cross-sectional 93 4–10 years Pf + Al + HK+ Tt 74–97 1. Similar Pf prevalence. 2.Frequency of associations not increased with increasing parasite loads Weak
14 Dejon_Agobe et al_2018 [4] Gabon 2012–2014 Longitudinal survey 739 NR Pf+ Al
Pf+ HK
Pf+ Tt
Pf+ Sh
23.6
25.6
29.5
9
1.Higher Pf incidence, with a significant delay of time-to first-malaria event only in children aged 6-10-years-old infected with Sh
2. Higher Pf risk
Strong
15 Degarege et al, 2014 [81] Ethiopia 2010–2011 Cross-sectional 702 NR Pf + STH 19.4 Similar Pf prevalence and risk of undernutrition Moderate
16 Deribew et al, 2013 [40] Ethiopia 2013 cross-sectional 387 6–23 months Pf+ Sh 2.84 1. Higher Pf prevalence, OR: 2.8; 95% CI: 1.21–6.5
2. Higher anaemia prevalence, OR: 10.12; 95% CI: 1.47–69.94
3. Similar mean Hb difference
Weak
17 Doumbo et al, 2018 [68] Mali 2011 Cross-sectional 688 3 months-25years Pf+ Sh 2.18 Higher Pf prevalence Moderate
18 Elfaki et al, 2015 [69] Sudan 2008–2009 Cross-sectional 250 6–16 years Pf+ Sh
Pf+ Sm
6.4
4
Higher Pf prevalence Weak
19 Green et al, 2011 [41] Uganda 2009 Cross-sectional 573 0.4–6 years Pf+ Sm
Pf + STH
28.7
1.8
Similar prevalence of anaemia and Hb levels Moderate
453 2–6 years Pf+ Sm
Pf + STH
20.1
6.3
20 Kepha et al, 2014 [42] Kenya 2013 Cross-sectional 5471 5–18 years Pf+ Al
Pf+ HK
7.8
9
Higher Pf risk when adjusted for age and gender Moderate
21 Kinugh’hi et al, 2014 [71] Tanzania 2006 Cross-sectional 1546 3–13 years Pf+ HK
Pf+ Sh
15.8
10.2
Similar Pf prevalence (OR: 1.19; 95% CI: 0.86–1.63) Moderate
22 Kwenti et al, 2016 [43] Cameroon 2014–2015 Cross-sectional 405 1 week-120 months Pf + STH 11.6 Similar Pf prevalence Moderate
23 Salim et al, 2015 [77] Tanzania 2011–2012 Cross-sectional 992 6 months -9 years Pf+ HK
Pf+ Tt
Pf + Sh
1.4
0.1
0.2
Higher Pf prevalence and risk (OR = 1.7, 95%
CI = 1.1–2.5
Moderate
24 Matangila et al, 2014 [72] DR Congo 2012 Cross-sectional 989 4–13 years Pf+ STH
Pf+ Sm
6.4
1.5
1.Similar Pf prevalence
2. Lower anaemia prevalence
Moderate
25 Mazigo et al, 2010 [73] Tanzania 2009 Cross-sectional 400 8–16 years Pf+ HK
Pf + Sm
2.3
5.5
1. Similar Pf prevalence (aOR: 1.35; 95%
CI: 0.49–3.72)
2. Higher Pf prevalence OR: 2.1; 95% CI: 1.03, 4.26
Moderate
26 Mboera et al, 2011 [83] Tanzania 2005 Cross-sectional 578 7.96 ± 1.4 years Pf + HK
Pf + Sh
5.3
10.9
Higher Pf density (P < 0.001) Moderate
27 Morenikeji et al, 2016 [74] Nigeria NR Cross-sectional 173 6–18 years Pf + Sh 62.3 Similar Pf risk OR: 0.8, 95% CI: 0.3–1.7, P = 0.507 Moderate
28 Nankabirwa et al, 2013 [14] Uganda 2011 Cross-sectional 740 6–14 years Pf +Al
Pf + HK
Pf + Tt
28.9
40
66.7
Similar Pf prevalence Moderate
29 Njunda et al, 2015 [44] Cameroon 2012 Cross-sectional 411 0–10 years Pf + STH 11.9 1.Similar Pf prevalence
2.Similar anaemia prevalence and mean Hb difference
Moderate
30 Nkuo-Akenji et al, 2006 [75] Cameroon 2004 Cross-sectional 425 0–14 years Pf+ Al
Pf + HK
Pf + Tt
7.5
0.2
7.8
1. Similar Pf prevalence (OR: 1.00; 95% CI: 0.65–1.53)
2. Higher Pf density (P < 0.001)
3. Similar anaemia prevalence (OR: 1.19; 95% CI: 0.642.21)
Moderate
31 Nyarko et al, 2018 [45] Ghana NR Cross-sectional 404 9–14 years Pf + Sh 12.9 Similar Pf prevalence Moderate
32 Obi et al, 1996 [76] Nigeria NR Cross-sectional 268 5–15 years Pf + Sh 21.3 NR Weak
33 Ojurongbe et al, 2011 [82] Nigeria 2009 Cross-sectional 117 4–15 years Pf + Al
Pf + HK
Pf + Tt
13.3
6.7
3.3
1.Higher Pf prevalence
2. Similar anaemia prevalence
Moderate
34 Tchinda et al, 2012 [78] Cameroon NR Cross-sectional 503 3–16 years Pf + Al 49.6 1.Higher Pf prevalence: OR = 1.61, 95% CI = 1.05–2.44, P = 0.028
2.Higher anaemia risk: OR = 1.64, 95% CI: 0.98–2.75; p = 0.059
Moderate
35 Yapi et al, 2014 [79] Senegal 2011–2012 Cross-sectional 5104 5–16 years Pf + STH
Pf + Sh
13.5
5.6
Higher Pf risk: IRR = 0.7, 95% CI = 0.6–0.8, P = 0.001 Strong
36 Zeukeng et al, 2014 [80] Cameroon 2011 Cross-sectional 152 1–14 years Pf + Al
Pf+ HK
Pf + Tt
21.1
4.61
8.7
1.Higher Pf prevalence
2.Higher anaemia prevalence
Moderate
37 Njua-Yafi et al, 2016 [46] Cameroon 2011–2012 Cross-sectional 357 6 months -10 years Pf + STH 2.9 1.Higher Pf prevalence: OR = 4.45, 95% CI (1.66–11.94), p = 0.003
2.Higher mean Hb levels (p<0.006)
Moderate
38 Le Hesran et al, 2004 [47] Senegal 2001–2002 Case-control 105 Mean age = 6.6 ±3 years Pf + Sh 10.3 1.Higher Pf risk: OR = 9.95, 95% CI = 3.03–32.69 Weak
39 Lemaitre et al, 2014 [48] Senegal 2001–2003 Cross-sectional 523 5–13 years Pf + Sh NR Higher Pf density: OR = -0.28, 95% CI: −0.52, −0.039, P = 0.10 Weak
40 Nacher et al, 2012 [49] Thailand 1998–1999 Cross-sectional 731 Median age = 17 years Pf + STH 12.7 Higher Pf risk Moderate
41 Stefani et al, 2017 [50] French Guiana 2001–2009 Cross-sectional 91 0–7 years Pv+ HK
Pv + Al
35.5
46.5
Higher Pv relapse: OR = 0.36, 95% CI = 0.94–1.4, p = 0.09 Moderate
42 Lyke et al, 2005 [51] Mali 2002–2003 Case-control 654 4–14 years Pf + Sh 44.5 1. Lower Pf incidence in 4–8 y.o
2. Lower Pf density in children ages 4–8 y.o
3. Similar Hb level
Moderate
43 Sangweme et al, 2010 [17] Zimbabwe 2004–2005 Longitudinal cohort 605 6–17 years Pf+ Sh 30.7 1. Similar Pf prevalence
2. Lower Pf density
3. Similar mean Hb
4. Similar anaemia prevalence
Moderate
44 Adio et al, 2004 [62] Nigeria 2002 Cross-sectional 243 6 months -15 years Pf + Al
Pf + HK
Pf +Tt
26.3
16.5
20.2
1.Higher Pf density
2.Higher anaemia prevalence
Weak
45 Adedoja et al, 2015 [52] Nigeria 2003 Cross-sectional 154 1–15 years Pf + Sh 54.4 Higher Pf prevalence Weak
46 Righetti et al, 2011 [53] Ivory Coast 2010 Cross sectional 147 5–14 years Pf + HK
Pf + Sh
27.9
8.8
1. Higher Pf prevalence (in 6–8 year-old) (aOR: 7.47–95% CI: 1.84–30.32)
2. Lower anaemia prevalence (OR: 0.23; 95% CI: 0.06–0.83)
Moderate
47 Abanyie et al, 2013 [54] Nigeria 2006–2007 RCT 690 6–59 months Pf + Al 42.9 1. Similar Pf prevalence (OR: 1.30; 95%
CI: 0.91–1.86)
2. Lower anaemia prevalence (OR: 0.50; 95% CI: 0.28–0.87); severity of malarial anaemia not altered by Pf-Al co-infection
3. Similar Pf density (p = 0.965)
Moderate
48 Roussihon et al, 2010 [55] Senegal 2000–2005 Longitudinal study 203 1–14 years Pf+ STH 0.655/child/year; ratio of malaria attack incidence density = 1: 1.723 1.Higher Pf incidence (aOR: 2.69; 95% CI: 1.34–5.39)
2.Incidence of malaria attacks is increased in helminth-infected children
Moderate
49 Kirwan et al, 2010 [56] Nigeria 2006–2007 RCT 320 6–59 months Pf + Al NR 1. Similar Pf prevalence (OR: 1.16; 95% CI: 0.73–1.85)
2. Similar rate of increase in Pf density
3. Similar rate of increase in Hb levels
4. Repeated 4-monthly administration of anti-helminth lowers Pf prevalence, coincided with a reduction in both Al prevalence and intensity
Strong
50 Ateba-Ngoa et al, 2015 [57] Gabon 2011 Cross-sectional 125 6–16 years Pf+ Sh 26 1. Similar magnitude between the two groups
2. Higher mean Hb difference: OR = 0.7; 95% CI: 0.21, 1.19
3. Increased immune response due to Pf
Moderate
51 Florey et al, 2012 [58] Kenya 2006 Cross-sectional 223 8–17 years Pf + Sh 36.3
15.4
1. Higher Pf prevalence, adjusted OR: 1.79; 95% CI: 1.32, 2.44
2. Children with heavy Pf more likely to have concomitant heavy Sh
Moderate
52 Courtin et al, 2011 [59] Senegal 2003 Longitudinal survey 203 6–16 years Pf+ Sh NR 1. Similar Pf prevalence, OR: 1.62; 95% CI: 0.94, 2.80
2. Similar Pf density
3. Additive effect of S. haem and Pf on the cytokine levels (elevated IL-10)
Moderate
53 Kabatereine et al, 2011 [70] Uganda 2009–2010 Cross-sectional 3569 10–14 years Pf + Sm
Pf + STH
23.51
13.79
Higher Pf prevalence, OR: 2.16; 95% CI: 1.89, 2.47 Moderate
54 Alemu et al, 2012 [63] Ethiopia 2011 Cross-sectional 108 1–14 years Pf + STH 30 1.Higher Pf prevalence
2.Higher anaemia prevalence: OR = 13.800, 95% CI = 4.871–39.093, P<0.0001
Moderate
55 Sokhna et al, 2004 [19] Senegal, 2008 Cross-sectional 512 6–15 years Pf + Sm 13.3 Higher Pf incidence in children with heavy S. mansoni egg load compared with uninfected (RR: 2.24, 95% CI:1.20, 4.20) Moderate

Twenty-seven studies compared the odds of asymptomatic/uncomplicated or severe P. falciparum infection and 16 studies compared P. falciparum density among children infected and uninfected with helminths. Fourteen studies compared the mean haemoglobin concentration or prevalence of anaemia among study participants who had Plasmodium and helminth infections and those infected with Plasmodium infection only. Most of the studies reported asymptomatic and/or uncomplicated Plasmodium infection except three studies [43, 47, 54], which reported severe malaria. Seven studies [19, 37, 53, 55, 57, 59, 65] reported antibody and/or cytokine expression in P. falciparum malaria-STH/Schistosoma co-infections.

Prevalence of Plasmodium-helminth co-infections

Overall, the pooled analysis showed that the prevalence of Plasmodium-STH co-infections in 22,114 children enrolled in 28 studies evaluating both groups of infection, in 13 countries across Central, East, West and Southern Africa, Southeast Asia and South America was 17.7% (95% CI 12.7–23.2%) (Fig 2). There was statistical heterogeneity (I2: 98.7%), suggesting a high level of heterogeneity among the included studies, although Egger’s regression test did not reach statistical significance (Egger’s test = 1.5039, p-value = 0.1388) (Fig 3). In a subgroup analysis, the pooled estimates showed that South America had the highest prevalence of 76.3% of co-infections, followed by Southern Africa (30.7%), West Africa (25.4%), East Africa (16.3%), Central Africa (13.1%) and South-east Asia (7.1%) (S1 Fig). Disaggregated by helminth types, the pooled prevalence of Plasmodium-Schistosoma co-infections in 9,803 children was 19.2% (95% CI: 9.6–31.1%); and the pooled prevalence of Plasmodium-STH co-infections in 12311 children was 17% (95%CI: 11.4–23.4%); (95% CI: 9.6–31.1%) (Fig 2). In a subgroup analysis of 12 studies reporting co-infection of Plasmodium and individual STH types in 6325 children, the prevalence for P.falciparum-A. lumbricoides co-infection was 24% (95% CI: 11.3–39.6%), P.falciparum-hookworm 12.8% (95% CI: 4.8–23.9%) and P. falciparum-T.trichuria 9.9% (95% CI: 2.6–21.4%) (S2A, S2B and S2C Fig, respectively). For Plasmodium falciparum-S. haematobium co-infection, the pooled prevalence was 24.4% (95% CI: 11.9–39.6%) and 6.7% (95% CI: 1.8–14.6%) for Plasmodium falciparum-S. mansoni co-infection (S3A and S3B Fig, respectively). The funnel plot generated using the cases of Plasmodium-helminth co-infections compared with children infected with Plasmodium mono-infection and the standard error estimates of the prevalence was asymmetric, in keeping with the high level of heterogeneity between the included studies, but as indicated above, the Egger’s regression test was not statistically significant (Egger’s test = 1.5039, p-value = 0.1388) (Fig 3).

Fig 2. Forest plot showing overall pooled prevalence of Plasmodium-helminth co-infections among children living in LMIC in studies which evaluated the prevalence of both groups of infection.

Fig 2

Fig 3. Funnel plot showing distributions of included studies.

Fig 3

Interactions of Plasmodium and helminths during co-infection

Given a very high level of heterogeneity between the studies, random-effects models were used to calculate the summary odds ratio in this meta-analysis. The overall estimates on 24 studies showed lower odds of asymptomatic/uncomplicated or severe P. falciparum infection in children co-infected with STH when compared with those with Plasmodium only (summary OR: 0.42; 95%CI: 0.28–0.64; I2 = 96.2%) (Fig 4). Similarly, the overall estimates in 20 studies showed lower odds of asymptomatic/uncomplicated P. falciparum infection among children co-infected with Schistosoma spp. compared with those with Plasmodium infection only (summary OR: 0.65; 95%CI: 0.37–1.16; I2 = 96.8%), although the odds-ratio did not reach statistical significance (Fig 5). Compared with children who had Plasmodium infection only, sub-group analyses showed similar lower odds in the summary estimates in children who had co-infection with Plasmodium-STH sub-types: A. lumbricoides - 0R =: 0.39, 95% CI: 0.12–1.23, I2 = 96.1%); hookworm–OR = 0.31, 95%CI 0.12–0.80, I2 = 96.8%); T.trichuria–(OR = 0.15, 95% CI 0.03–0.77; I2 = 97.8%) (S2A, S2B and S2C Fig, respectively). For Plasmodium-S. haematobium and Plasmodium-S. mansoni, the OR was 0.76, 95% CI: 0.41–1.41; I2 = 99.1% and OR:0.39, 95% CI: 0.1–1.58, I2 = 99.0% respectively (S3A and S3B Fig, respectively). When adjusted for age, gender, socio-economic status, nutrition status and geographic locations of the children, the risk of asymptomatic/uncomplicated or severe P. falciparum infection in children co-infected with STH was higher compared with children who did not have STH infection (OR = 1.3, 95% CI 1.03–1.65; I2 = 32.1%). (S4 and S5 Figs).

Fig 4. Forest plot showing the risk of asymptomatic/uncomplicated or severe P. falciparum infection in children co-infected with STH compared with children who did not have STH infection.

Fig 4

Fig 5. Forest plot showing the risk of asymptomatic/uncomplicated or severe P. falciparum infection in children co-infected with Schistosoma spp compared with children who did not have Schistosoma infection.

Fig 5

Risk of Anaemia in Plasmodium-helminth co-infections

In 15 studies [35,44,46,5254,6264,71,75,78,80,8384], the odds of anaemia were higher in children who were co-infected with Plasmodium species and pooled STH species compared to those who were infected with P. falciparum alone (summary OR = 1.20 (95% CI: 0.59–2.45, I2 = 96.3%) (Fig 6). In contrast, the odds of anaemia were almost equal in six studies [17, 40, 61, 71, 72, 83] involving children who were co-infected with Plasmodium species and pooled Schistosoma species compared to those who were infected with P. falciparum alone (summary OR = 0.97, 95% CI: 0.30–3.14; I2 = 97.8%) (Fig 7).

Fig 6. Forest plot showing odds of anaemia in children co-infected with Plasmodium species and pooled STH species compared with those who were infected with P. falciparum alone.

Fig 6

Fig 7. Forest plot showing odds of anaemia in children co-infected with Plasmodium species and pooled Schistosoma spp compared with those who were infected with P. falciparum alone.

Fig 7

Narrative review

Roles of biologic factors on malaria-helminth co-infection

Four studies [42,43,52,58] explored the roles of biological factors such as age and gender in the epidemiology of Plasmodium-helminth co-infections. The prevalence of hookworm-Plasmodium co-infection was significantly higher in boys than girls, but no gender difference was observed in the prevalence of A. lumbricoides-Plasmodium co-infection [42, 43]. Children had 9.3 times the odds of co-infection compared to adults (95%CI = 5.3–16.3), with children aged 7–9 years most frequently co-infected with S. haematobium followed by the age group 4–6 years [58]. This finding is in agreement with that of another study [52] but conflicts with other findings [85].

Interactions between malaria and helminth

A Kenyan study [58] reported that the odds of intensity of S. haematobium infection increased with increasing Plasmodium infection intensity, consistent with similar with findings of studies from Senegal [48], Mali [67, 68], Thailand [49] and Zimbabwe [17]. These findings conflict with those of two RCTs conducted in Madagascar which reported a negative interaction between P. falciparum and S. haematobium light infections [38], between A. lumbricoides and malaria parasite density [39] and of another study which showed that S. mansoni increased susceptibility to malaria [19]. Two studies [43, 47] reported that A. lumbricoides exerted a protective impact on the severity and patency of malaria clinical infections [50], in agreement with the findings of another study [56] which showed that administration of anti-helminth drugs lowered the prevalence and intensity of A. lumbricoides infections and also the prevalence of Plasmodium infection.

Anaemia induced by malaria-helminth co-infection

Seven [34, 35, 40, 44, 46, 53, 54] of the 27 studies analysed for narrative reviews also contributed to the data synthesis for the odds of anaemia in Plasmodium-helminth co-infection described above. Four of these studies [34, 35, 40, 46] showed a lower mean haemoglobin values for children with Plasmodium-helminth co-infections than children with either Plasmodium or helminth infection only. Humphries et al in two studies [35, 36] reported that the risk of anaemia was lower in Ghanaian children co-infected with malaria and hookworm than in those with malaria alone, suggesting that hookworm may modulate the pathogenesis of P. falciparum. This is similar with findings from Deribew et al [40], but deviates from findings of other studies [41, 46, 53, 54].

Immuno-modulating effects of helminths on malaria

Three studies [55, 57, 59] reported the immuno-modulating effect of helminths on the clinical course of malaria. A significant correlation was observed between the occurrence of malaria attacks, hookworm carriage and a decrease in cytophilic IgG1 and IgG3 malaria responses, suggesting that helminth infection might increase malaria morbidity through a Th2 worm-driven pattern of anti-malarial immune responses [55]. This is consistent with a Senegalese study [59] in which higher circulating levels of interleukin-10 in the plasma of co-infected children were associated with decreased anti-plasmodial IgG responses, but disagrees with the findings of another study in which no effect of S. haematobium was observed on the innate and adaptive immune response among Gabonese children infected with P. falciparum [57].

Quality of the included studies

We assessed the quality of the studies included in this review, and observed that majority of the studies had strong quality in design. Overall rating based on the assessment criteria showed that four studies were of strong quality, 41 studies were of moderate quality and the quality of 10 studies was weak (Table 1). None of the studies was excluded from the review as a result of quality issues.

Discussion

Burden of malaria-helminth co-infections

This systematic review with meta-analysis of 28 studies involving 22,114 children across 13 endemic countries showed an overall prevalence of malaria-helminth co-infection of 17.7%. Expectedly, sub-analysis showed that the prevalence varied according to geographic regions of LMIC, with the prevalence being highest in South America region and lowest in Southeast Asia. The small sample size of the single study which satisfied eligibility for inclusion in this review from South America, is likely to explain the very high prevalence observed in this region. This is in contrast with a low prevalence observed in Southeast Asia region, although the only included study had a relatively bigger sample size. The small number of studies reviewed from outside SSA means that no general conclusions can be made about the frequency of Plasmodium-helminth co-infections between continents. The pooled prevalence rates observed among the larger number of studies undertaken in SSA ranged from 13.1 to 30.7%. These are similar findings to those of a previous review [86]. Apart from environmental factors which promote the co-existence of malaria and helminth infections in LMIC, a high prevalence of co-infection in these settings has been attributed to prevalent infrastructural and behavioural problems such as poor sanitation, lack of toilet facilities, unsafe drinking water, and ineffective public health enlightenment programmes [86].

Nature of interactions between malaria and helminths

Meta-analysis of the 24 studies in this review revealed lower odds of prevalent malaria in children co-infected with either STH or Schistosoma spp, but higher odds in children with malaria-STH co-infection when adjusted for confounders. This is similar to the findings of reviews conducted by Dagarege et al [7]. Also, narrative reviews conducted as part of this systematic review showed conflicting findings, with positive linear relationship between Plasmodium falciparum and S.haematobium in Kenyan, Senegalese, Thai and Zimbabwean children [17, 48, 49, 58] but negative interactions reported in Malagasy children [38, 39] and between P. falciparum and S.mansoni in another Senegalese paediatric population [19]. These conflicting findings underscore the complexity in the interactions between P.falciparum and helminths. The variations may also be influenced by the nature of immune responses elicited by the dual infections. Given the variability in the mechanisms of immune activation by helminths and Plasmodium parasites [16], and the fact that helminths downregulate immune responses to Plasmodium pathogens [57, 87], previous studies suggested that STH infections increase risk to Plasmodium infection and related clinical outcomes [55, 65].

Risk of anaemia from malaria-helminth co-infections

The summary estimates from 16 studies in this review showed that the odds of anaemia were higher in children who were co-infected with Plasmodium and STH species than in children infection with Plasmodium alone. These findings are consistent with review by Naing et al [26], but not with findings of review by Dagarege et al [7]. The negative effect of Plasmodium-helminth co-infection on anaemia is not surprising considering the different mechanisms by which anaemia is produced in the two infections [2, 63, 88,89].

The pooled estimates from six studies in this review of Plasmodium-Schistosoma co-infection showed an equal odd of anaemia in co-infected children compared with uninfected children. This is not in keeping with the finding of a previous review [8], which reported a higher mean haemoglobin concentration in children co-infected with S. haematobium and P. falciparum than in those infected with only P. falciparum. A reason for this difference might be due to the relatively low number of primary studies used in calculating the summary estimates for the mean haemoglobin differences. Nevertheless, the finding of this review supports the postulated mechanisms modulating anaemia in Schistosoma-Plasmodium co-infection [40, 55, 59, 74].

Study limitations

This systematic review did not escape from the limitations identified in previous reviews. Most of the primary studies included in this reviews were cross-sectional in design, making it challenging to conclusively establish the prevalence of malaria-helminth co-infections in LMIC. A very high level of heterogeneity was also observed among the included studies, although Egger’s test did not reach statistical significance thereby ruling out the possibility of publication bias. Bias may have been introduced given that the primary studies were conducted in widely diverse populations, with significant variations in the study designs and methodologies adopted in implementing these primary studies. Nevertheless, this review has updated the body of knowledge on malaria-helminth co-infection through a comprehensive synthesis of data obtained from studies conducted across LMIC.

Conclusion

In conclusion, we have shown that the prevalence of malaria-helminth co-infection is high in studies which evaluated the prevalence of both groups of infections in children living in endemic countries. The nature of interactions between malaria and helminth infection and impact of the co-infection on anaemia remain inconclusive, and may be modulated by immune responses of the affected children. Findings of this review support our resolve to employ improved tools to quantify the burden of malaria-helminth co-infections. This may generate better understanding of burden of the co-infection, which could be deployed for planning and implementation of appropriate interventions for integrated control and, ultimately elimination of both groups of infections. Exploring the dynamics of immune regulation in malaria and helminth co-infection may also be useful in malaria vaccine development to understand the influence of the dual infection on vaccine immunogenicity [2].

Supporting information

S1 Fig. Forest plot showing pooled prevalence of malaria-helminth co-infection by geographic region.

(DOCX)

S2 Fig

a-b-c: Forest plot showing sub-group analysis of summary estimates of prevalence of P.falciparum-A. lumbricoides co-infection, forest plot showing sub-group analysis of summary estimates of prevalence of P.falciparum-hookworm co-infection, forest plot showing sub-group analysis of summary estimates of prevalence of P.falciparum-T.trichuria co-infection.

(DOCX)

S3 Fig

a-b: Forest plot showing sub-group analysis of prevalence of Plasmodium-S. haematobium co-infection in children in LMIC, forest plot showing sub-group analysis of prevalence of Plasmodium-S.mansoni co-infection in children in LMIC.

(DOCX)

S4 Fig. Forest plot showing the risk of asymptomatic/uncomplicated or severe P. falciparum infection in children co-infected with STH compared with children who did not have STH infection when adjusted for geographic location of the study participants.

(DOCX)

S5 Fig. Forest plot showing the risk of asymptomatic/uncomplicated or severe P. falciparum infection in children co-infected with STH compared with children who did not have STH infection when adjusted for age, gender, socio-economic status and nutrition status of the children.

(DOCX)

S1 File. Study protocol including the search strategy.

(PDF)

Acknowledgments

We appreciate the support and guidance on the refinement of the search strategy by Jane Falconer and colleagues at the Library and Archive Services of the London School of Hygiene & Tropical Medicine, UK.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was implemented as part of a career development fellowship awarded to MOA, which is funded under UK Research and Innovation Future Leaders Fellowship scheme (MR/S03286X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Steinmann P, Utzinger J, Du ZW, Zhou XN. Multiparasitism a neglected reality on global, regional and local scale. Adv Parasitol 2010;73:21–50. Epub 2010/07/16. 10.1016/S0065-308X(10)73002-5 . [DOI] [PubMed] [Google Scholar]
  • 2.Brooker S, Akhwale W, Pullan R, Estambale B, Clarke SE, Snow RW, et al. Epidemiology of Plasmodium-Helminth Co-Infection in Africa: Populations at Risk, Potential Impact on Anemia, and Prospects for Combining Control. The American journal of tropical medicine and hygiene. 2007;77(6_Suppl):88–98. 10.4269/ajtmh.2007.77.88 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Degarege A, Legesse M, Medhin G, Animut A, Erko B. Malaria and related outcomes in patients with intestinal helminths: a cross-sectional study. BMC Infect Dis. 2012;12:291. Epub 2012/11/10. 10.1186/1471-2334-12-291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Dejon-Agobe JC, Zinsou JF, Honkpehedji YJ, Ateba-Ngoa U, Edoa JR, Adegbite BR, et al. Schistosoma haematobium effects on Plasmodium falciparum infection modified by soil-transmitted helminths in school-age children living in rural areas of Gabon. PLoS neglected tropical diseases. 2018;12(8):e0006663. Epub 2018/08/07. 10.1371/journal.pntd.0006663 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.World malaria report 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. Available from: https://www.who.int/publications-detail/world-malaria-report-2019. Accessed 20 Jan 2020.
  • 6.2030 targets for soil-transmitted helminthiases control programmes. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. Available from: https://www.who.int/intestinal_worms/resources/9789240000315/en/. Accessed 20 Jan 2020.
  • 7.Degarege A, Veledar E, Degarege D, Erko B, Nacher M, Madhivanan P. Plasmodium falciparum and soil-transmitted helminth co-infections among children in sub-Saharan Africa: a systematic review and meta-analysis. Parasit Vectors. 2016;9(1):344. Epub 2016/06/17. 10.1186/s13071-016-1594-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Degarege A, Degarege D, Veledar E, Erko B, Nacher M, Beck-Sague CM, et al. Plasmodium falciparum Infection Status among Children with Schistosoma in Sub-Saharan Africa: A Systematic Review and Meta-analysis. PLoS neglected tropical diseases. 2016;10(12):e0005193. Epub 2016/12/08. 10.1371/journal.pntd.0005193 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hotez PJ, Molyneux DH. Tropical anemia: one of Africa’s great killers and a rationale for linking malaria and neglected tropical disease control to achieve a common goal. PLoS neglected tropical diseases. 2008;2(7):e270. Epub 2008/07/31. 10.1371/journal.pntd.0000270 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ezeamama AE, McGarvey ST, Acosta LP, Zierler S, Manalo DL, Wu HW, et al. The synergistic effect of concomitant schistosomiasis, hookworm, and trichuris infections on children’s anemia burden. PLoS neglected tropical diseases. 2008;2(6):e245. Epub 2008/06/05. 10.1371/journal.pntd.0000245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sousa-Figueiredo JC, Gamboa D, Pedro JM, Fançony C, Langa AJ, Magalhães RJS, et al. Epidemiology of malaria, schistosomiasis, geohelminths, anemia and malnutrition in the context of a demographic surveillance system in northern Angola. PloS one. 2012;7(4):e33189–e. Epub 2012/04/06. 10.1371/journal.pone.0033189 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ezeamama AE, Bustinduy AL, Nkwata AK, Martinez L, Pabalan N, Boivin MJ, et al. Cognitive deficits and educational loss in children with schistosome infection-A systematic review and meta-analysis. PLoS neglected tropical diseases. 2018;12(1):e0005524. Epub 2018/01/13. 10.1371/journal.pntd.0005524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Pabalan N, Singian E, Tabangay L, Jarjanazi H, Boivin MJ, Ezeamama AE. Soil-transmitted helminth infection, loss of education and cognitive impairment in school-aged children: A systematic review and meta-analysis. PLoS neglected tropical diseases. 2018;12(1):e0005523. Epub 2018/01/13. 10.1371/journal.pntd.0005523 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Nankabirwa J, Wandera B, Kiwanuka N, Staedke SG, Kamya MR, Brooker SJ. Asymptomatic Plasmodium infection and cognition among primary schoolchildren in a high malaria transmission setting in Uganda. The American journal of tropical medicine and hygiene. 2013;88(6):1102–8. Epub 2013/04/15. 10.4269/ajtmh.12-0633 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Degarege A, Erko B. Epidemiology of Plasmodium and Helminth Coinfection and Possible Reasons for Heterogeneity. Biomed Res Int. 2016;2016:3083568. Epub 2016/04/20. 10.1155/2016/3083568 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hartgers FC, Yazdanbakhsh M. Co-infection of helminths and malaria: modulation of the immune responses to malaria. Parasite Immunol 2006;28(10):497–506. Epub 2006/09/13. 10.1111/j.1365-3024.2006.00901.x . [DOI] [PubMed] [Google Scholar]
  • 17.Sangweme DT, Midzi N, Zinyowera-Mutapuri S, Mduluza T, Diener-West M, Kumar N. Impact of schistosome infection on Plasmodium falciparum Malariometric indices and immune correlates in school age children in Burma Valley, Zimbabwe. PLoS neglected tropical diseases. 2010;4(11):e882. Epub 2010/11/19. 10.1371/journal.pntd.0000882 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Nacher M. Interactions between worms and malaria: good worms or bad worms? Malar J. 2011;10:259. Epub 2011/09/14. 10.1186/1475-2875-10-259 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sokhna C, Le Hesran J-Y, Mbaye PA, Akiana J, Camara P, Diop M, et al. Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal. Malaria journal. 2004;3:43–. 10.1186/1475-2875-3-43 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Adegnika AA, Kremsner PG. Epidemiology of malaria and helminth interaction: a review from 2001 to 2011. Curr Opin HIV AIDS 2012;7(3):221–4. Epub 2012/03/16. 10.1097/COH.0b013e3283524d90 . [DOI] [PubMed] [Google Scholar]
  • 21.The Malaria Atlas Project. Available from: https://malariaatlas.org/. Accessed 12 June 2020.
  • 22.Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN). Available from: https://espen.afro.who.int/. Accessed 12 June 2020.
  • 23.Global Atlas of Helminth Infections> Available from: http://www.thiswormyworld.org/. Accessed 12 June 2020.
  • 24.Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009. Jul 21;6 (7):e1000097. 10.1371/journal.pmed.1000097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Morgan RL, Whaley P, Thayer KA, Schünemann HJ. Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes. Environment international. 2018;121(Pt 1):1027–31. Epub 2018/09/01. 10.1016/j.envint.2018.07.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Naing C, Whittaker MA, Nyunt-Wai V, Reid SA, Wong SF, Mak JW, et al. Malaria and soil-transmitted intestinal helminth co-infection and its effect on anemia: a meta-analysis. Trans R Soc Trop Med Hyg. 2013;107 (11):672–83. 10.1093/trstmh/trt086 [DOI] [PubMed] [Google Scholar]
  • 27.Basic laboratory methods in medical parasitology. Available from: https://www.who.int/malaria/publications/atoz/9241544104_part1/en/. Accessed 21 July 2020.
  • 28.WHO/UNICEF/UNU. Iron deficiency anemia: assessment, prevention and control: a guide for programme managers. World Health Organization, Geneva. 2011. p. 114. Available from: https://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf. Accessed 21 July 2020.
  • 29.Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. 10.1186/s13643-016-0384-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2014. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. [Google Scholar]
  • 31.Effective Public Health Practice Project. Effective Public Health Practice Project. Dictionary for the Effective Public Health Practice Project Quality Assessment Tool For Quantitative Studies. Available from: http://www.ephpp.ca/PDF/QADictionary_dec2009.pdf. Accessed on 15 Jan 2020.
  • 32.Reviews in health promotion and public health. Cochrane Handbook for Systematic Reviews of Interventions. Retrieved from www.cochrane-handbook.org. Accessed 15 Jan 2020.
  • 33.Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from: www.training.cochrane.org/handbook. Accessed on 28 April 2020.
  • 34.Akanni EO, Adefioye OA, Akanni RA, Taiwo SS. Iron deficiency anaemia associated with helminths and asymptomatic malaria infections among rural school children in Southwestern Nigeria. Asian Pacific Journal of Tropical Disease. 2014;4:S590 –S4. 10.1016/S2222-1808(14)60684-8 [DOI] [Google Scholar]
  • 35.Humphries D, Mosites E, Otchere J, Twum WA, Woo L, Jones-Sanpei H, et al. Epidemiology of hookworm infection in Kintampo North Municipality, Ghana: patterns of malaria coinfection, anemia, and albendazole treatment failure. The American journal of tropical medicine and hygiene. 2011;84(5):792–800. 10.4269/ajtmh.2011.11-0003 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Humphries D, Simms BT, Davey D, Otchere J, Quagraine J, Terryah S, et al. Hookworm infection among school age children in Kintampo north municipality, Ghana: nutritional risk factors and response to albendazole treatment. The American journal of tropical medicine and hygiene. 2013;89(3):540–8. Epub 2013/07/08. 10.4269/ajtmh.12-0605 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Briand V, Watier L, JY LEH, Garcia A, Cot M. Coinfection with Plasmodium falciparum and schistosoma haematobium: protective effect of schistosomiasis on malaria in senegalese children? The American journal of tropical medicine and hygiene. 2005;72(6):702–7. Epub 2005/06/21. . [PubMed] [Google Scholar]
  • 38.Brutus L, Watier L, Briand V, Hanitrasoamampionona V, Razanatsoarilala H, Cot M. Parasitic co-infections: does Ascaris lumbricoides protect against Plasmodium falciparum infection? The American journal of tropical medicine and hygiene. 2006;75(2):194–8. 10.4269/ajtmh.2006.75.194 . [DOI] [PubMed] [Google Scholar]
  • 39.Brutus L, Watier L, Hanitrasoamampionona V, Razanatsoarilala H, Cot M. Confirmation of the protective effect of Ascaris lumbricoides on Plasmodium falciparum infection: results of a randomized trial in Madagascar. The American journal of tropical medicine and hygiene. 2007;77(6):1091–5. 10.4269/ajtmh.2007.77.1091 . [DOI] [PubMed] [Google Scholar]
  • 40.Deribew K, Tekeste Z, Petros B, Huat LB. Urinary schistosomiasis and malaria associated anemia in Ethiopia. Asian Pac J Trop Biomed. 2013;3(4):307–10. Epub 2013/04/27. 10.1016/S2221-1691(13)60068-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Green HK, Sousa-Figueiredo JC, BasÁÑEz M-G, Betson M, Kabatereine NB, Fenwick A, et al. Anaemia in Ugandan preschool-aged children: the relative contribution of intestinal parasites and malaria. Parasitology. 2011;138(12):1534–45. Epub 2011/08/08. 10.1017/S0031182011001016 [DOI] [PubMed] [Google Scholar]
  • 42.Kepha S, Nuwaha F, Nikolay B, Gichuki P, Edwards T, Allen E, et al. Epidemiology of coinfection with soil transmitted helminths and Plasmodium falciparum among school children in Bumula District in western Kenya. Parasites & vectors. 2015;8:314–. 10.1186/s13071-015-0891-5 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kwenti TE, Nkume FA, Tanjeko AT, Kwenti TDB. The Effect of Intestinal Parasitic Infection on the Clinical Outcome of Malaria in Coinfected Children in Cameroon. PLoS neglected tropical diseases. 2016;10(4):e0004673–e. 10.1371/journal.pntd.0004673 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Njunda AL, Fon SG, Assob JCN, Nsagha DS, Kwenti TDB, Kwenti TE. Coinfection with malaria and intestinal parasites, and its association with anaemia in children in Cameroon. Infectious diseases of poverty. 2015;4:43–. 10.1186/s40249-015-0078-5 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Nyarko R, Torpey K, Ankomah A. Schistosoma haematobium, Plasmodium falciparum infection and anaemia in children in Accra. Ghana Tropical Diseases, Travel Medicine and Vaccines. 2018;4 (1):3. 10.1186/s40794-018-0063-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Njua-Yafi C, Achidi EA, Anchang-Kimbi JK, Apinjoh TO, Mugri RN, Chi HF, et al. Malaria, helminths, co-infection and anaemia in a cohort of children from Mutengene, south western Cameroon. Malar J. 2016;15:69. Epub 2016/02/08. 10.1186/s12936-016-1111-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Le Hesran JY, Akiana J, Ndiaye el HM, Dia M, Senghor P, Konate L. Severe malaria attack is associated with high prevalence of Ascaris lumbricoides infection among children in rural Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2004;98(7):397–9. Epub 2004/05/13. 10.1016/j.trstmh.2003.10.009 . [DOI] [PubMed] [Google Scholar]
  • 48.Lemaitre M, Watier L, Briand V, Garcia A, Le Hesran JY, Cot M. Coinfection with Plasmodium falciparum and Schistosoma haematobium: additional evidence of the protective effect of Schistosomiasis on malaria in Senegalese children. The American journal of tropical medicine and hygiene. 2014;90(2):329–34. Epub 2013/12/09. 10.4269/ajtmh.12-0431 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Nacher M, Singhasivanon P, Yimsamran S, Manibunyong W, Thanyavanich N, Wuthisen P, et al. Intestinal helminth infections are associated with increased incidence of Plasmodium falciparum malaria in Thailand. J Parasitol. 2002;88(1):55–8. 4. 10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2 [DOI] [PubMed] [Google Scholar]
  • 50.Stefani A, Cheuret M, N’Guyen D, Simon S, Brousse P, Carme B, et al. Interactions between Gastrointestinal Nematodes and Malaria in a Cohort of Children in an Amazonian Village. J Trop Pediatr. 2016;63(2):144–7. 10.1093/tropej/fmw063 [DOI] [PubMed] [Google Scholar]
  • 51.Lyke KE, Dicko A, Dabo A, Sangare L, Kone A, Coulibaly D, et al. Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. The American journal of tropical medicine and hygiene. 2005;73(6):1124–30. Epub 2005/12/16. [PMC free article] [PubMed] [Google Scholar]
  • 52.Adedoja AA, Akanbi AA, Oshodi AJ. Effect of artemether-lumefantrine treatment of falciparum malaria on urogenital schistosomiasis in co-infected School Aged Children in North Central of Nigeria. International Journal of Biological and Chemical. Sciences. 2015;9(1):134–40. [Google Scholar]
  • 53.Righetti AA, Glinz D, Adiossan LG, Koua A-YG, Niamké S, Hurrell RF, et al. Interactions and potential implications of Plasmodium falciparum-hookworm coinfection in different age groups in south-central Côte d’Ivoire. PLoS neglected tropical diseases. 2012;6(11):e1889–e. Epub 2012/11/01. 10.1371/journal.pntd.0001889 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Abanyie FA, McCracken C, Kirwan P, Molloy SF, Asaolu SO, Holland CV, et al. Ascaris co-infection does not alter malaria-induced anaemia in a cohort of Nigerian preschool children. Malar J. 2013;12:1. Epub 2013/01/04. 10.1186/1475-2875-12-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Roussilhon C, Brasseur P, Agnamey P, Pérignon J-L, Druilhe P. Understanding human-Plasmodium falciparum immune interactions uncovers the immunological role of worms. PloS one. 2010;5(2):e9309–e. 10.1371/journal.pone.0009309 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Kirwan P, Jackson AL, Asaolu SO, Molloy SF, Abiona TC, Bruce MC, et al. Impact of repeated four-monthly anthelmintic treatment on Plasmodium infection in preschool children: a double-blind placebo-controlled randomized trial. BMC Infect Dis. 2010;10:277. Epub 2010/09/23. 10.1186/1471-2334-10-277 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Ateba-Ngoa U, Adegnika AA, Zinsou JF, Kassa Kassa RF, Smits H, Massinga-Loembe M, et al. Cytokine and chemokine profile of the innate and adaptive immune response of schistosoma haematobium and plasmodium falciparum single and co-infected school-aged children from an endemic area of Lambaréné. Gabon Malaria Journal. 2015;14 (1):94. 10.1186/s12936-015-0608-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Florey LS, King CH, Van Dyke MK, Muchiri EM, Mungai PL, Zimmerman PA, et al. Partnering parasites: evidence of synergism between heavy Schistosoma haematobium and Plasmodium species infections in Kenyan children. PLoS neglected tropical diseases. 2012;6(7):e1723–e. Epub 2012/07/24. 10.1371/journal.pntd.0001723 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Courtin D, Djilali-Saïah A, Milet J, Soulard V, Gaye O, Migot-Nabias F, et al. Schistosoma haematobium infection affects Plasmodium falciparum-specific IgG responses associated with protection against malaria. Parasite Immunol. 2011;33(2):124–31. Epub 2011/01/14. 10.1111/j.1365-3024.2010.01267.x . [DOI] [PubMed] [Google Scholar]
  • 60.Achidi EA, Apinjoh TO, Mbunwe E, Besingi R, Yafi C, Wenjighe Awah N, et al. Febrile status, malarial parasitaemia and gastro-intestinal helminthiases in schoolchildren resident at different altitudes, in south–western Cameroon. Annals of Tropical Medicine & Parasitology. 2008;102(2):103–18. 10.1179/136485908X252287 [DOI] [PubMed] [Google Scholar]
  • 61.Adedoja A, Tijani BD, Akanbi AA, 2nd, Ojurongbe TA, Adeyeba OA, Ojurongbe O. Co-endemicity of Plasmodium falciparum and Intestinal Helminths Infection in School Age Children in Rural Communities of Kwara State Nigeria. PLoS neglected tropical diseases. 2015;9(7):e0003940–e. 10.1371/journal.pntd.0003940 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Adio MB, Ndamukong KJ, Kimbi HK, Mbuh JV. Malaria and intestinal helminthiasis in school children of Kumba Urban Area, Cameroon East Afr Med J 2004;81(11):583–8. Epub 2005/05/05. . [PubMed] [Google Scholar]
  • 63.Alemu A, Shiferaw Y, Ambachew A, Hamid H. Malaria helminth co-infections and their contribution for aneamia in febrile patients attending Azzezo health center, Gondar, Northwest Ethiopia: a cross sectional study. Asian Pac J Trop Med 2012;5(10):803–9. Epub 2012/10/10. 10.1016/S1995-7645(12)60147-3 . [DOI] [PubMed] [Google Scholar]
  • 64.Burdam FH, Hakimi M, Thio F, Kenangalem E, Indrawanti R, Noviyanti R, et al. Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life. PloS one. 2016;11(8):e0160917–e. 10.1371/journal.pone.0160917 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Bwanika R, Kato CD, Welishe J, Mwandah DC. Cytokine profiles among patients co-infected with Plasmodium falciparum malaria and soil borne helminths attending Kampala International University Teaching Hospital, in Uganda. Allergy Asthma Clin Immunol. 2018;14:10. Epub 2018/03/22. 10.1186/s13223-018-0235-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Carmona-Fonseca J, Uscátegui Peñuela RM, Correa Botero AM. Parasitosis intestinal en niños de zonas palúdicas de Antioquia (Colombia). Iatreia. 2009;22:27–46. [Google Scholar]
  • 67.Doumbo S, Tran TM, Sangala J, Li S, Doumtabe D, Kone Y, et al. Co-infection of Long-Term Carriers of Plasmodium falciparum with Schistosoma haematobium Enhances Protection from Febrile Malaria: A Prospective Cohort Study in Mali. PLoS Negl Trop Dis. 2014;8(9):e3154. 10.1371/journal.pntd.0003154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Doumbo SN, Ongoïba A, Doumtabe D, Tran TM, Traoré A, Sangala J, et al. Prevalence of Malaria, Intestinal and Urinary parasite infections in Kalifabougou. Mali Mali Medical. 2018;33 (1):10–5. [PubMed] [Google Scholar]
  • 69.Elfaki TEM, Elhassan IM. Prevalence Rate of Malaria/ Helminthiasis Co-Infections in Genaid Irrigated Area, Gezira State, Sudan. Journal of Natural and Medical. Sciences. 2015;16(1):53–60. [Google Scholar]
  • 70.Kabatereine NB, Standley CJ, Sousa-Figueiredo JC, Fleming FM, Stothard JR, Talisuna A, et al. Integrated prevalence mapping of schistosomiasis, soil-transmitted helminthiasis and malaria in lakeside and island communities in Lake Victoria. Uganda Parasites & Vectors. 2011;4(1):232. 10.1186/1756-3305-4-232 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Kinung’hi SM, Magnussen P, Kaatano GM, Kishamawe C, Vennervald BJ. Malaria and helminth co-infections in school and preschool children: a cross-sectional study in Magu district, north-western Tanzania. PloS one. 2014;9(1):e86510–e. 10.1371/journal.pone.0086510 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Matangila JR, Doua JY, Linsuke S, Madinga J, Inocêncio da Luz R, Van Geertruyden J-P, et al. Malaria, schistosomiasis and soil transmitted helminth burden and their correlation with anemia in children attending primary schools in Kinshasa, Democratic Republic of Congo. PloS one. 2014;9(11):e110789–e. 10.1371/journal.pone.0110789 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Mazigo HD, Kidenya BR, Ambrose EE, Zinga M, Waihenya R. Association of intestinal helminths and P. falciparum infections in co-infected school children in northwest Tanzania. Tanzan J Health Res. 2010;12(4):283–5. [DOI] [PubMed] [Google Scholar]
  • 74.Morenikeji OA, Eleng IE, Atanda OS, Oyeyemi OT. Renal related disorders in concomitant Schistosoma haematobium-Plasmodium falciparum infection among children in a rural community of Nigeria. J Infect Public Health 2016;9(2):136–42. Epub 2015/07/30. 10.1016/j.jiph.2015.06.013 . [DOI] [PubMed] [Google Scholar]
  • 75.Nkuo-Akenji TK, Chi PC, Cho JF, Ndamukong KKJ, Sumbele I. Malaria and helminth co-infection in children living in a malaria endemic setting of Mount Cameroob and predictors of anemia. Journal of Parasitology. 2006;92(6):1191–5, 5. [DOI] [PubMed] [Google Scholar]
  • 76.Obi AA Yesufu HM, Fagbenro-Beyioku AF and Obi CL. Concurrent Infections with Schistosomiasis Typhoid Fever and Malaria among Patients in Edo State Nigeria. 1996. Acta Medica et Biologica;44(4):215–219. [Google Scholar]
  • 77.Salim N, Knopp S, Lweno O, Abdul U, Mohamed A, Schindler T, et al. Distribution and risk factors for Plasmodium and helminth co-infections: a cross-sectional survey among children in Bagamoyo district, coastal region of Tanzania. PLoS neglected tropical diseases. 2015;9(4):e0003660. Epub 2015/04/04. 10.1371/journal.pntd.0003660 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Tchinda VHM, Ponka R, Ndzi ES, Madocgne AK, Amédée M, Tchinda MG, Moyou RS. Prevalence of malaria and soil-transmitted helminth infections and their association with undernutrition in schoolchildren residing in Mfou health district in Cameroon. Journal of Public Health and Epidemiology. 2012;4(9):253–260. (n). [Google Scholar]
  • 79.Yapi RB, Hürlimann E, Houngbedji CA, Ndri PB, Silué KD, Soro G, et al. Infection and co-infection with helminths and Plasmodium among school children in Côte d’Ivoire: results from a National Cross-Sectional Survey. PLoS neglected tropical diseases. 2014;8(6):e2913–e. 10.1371/journal.pntd.0002913 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Zeukeng F, Tchinda VHM, Bigoga JD, Seumen CHT, Ndzi ES, Abonweh G, et al. Co-infections of malaria and geohelminthiasis in two rural communities of Nkassomo and Vian in the Mfou health district, Cameroon. PLoS neglected tropical diseases. 2014;8(10):e3236–e. 10.1371/journal.pntd.0003236 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Degarege A, Animut A, Legesse M, Medhin G, Erko B. Malaria and helminth co-infection and nutritional status of febrile patients in Southern Ethiopia. J Infect Public Health 2014;7(1):32–7. Epub 2013/09/04. 10.1016/j.jiph.2013.05.007 . [DOI] [PubMed] [Google Scholar]
  • 82.Ojurongbe O, Adegbayi AM, Bolaji OS, Akindele AA, Adefioye OA. Adeyeba OA Asymptomatic falciparum malaria and intestinal helminths coinfection among school children in Osogbo. Nigeria J Res Med Sci. 2011;16(5):680–6. [PMC free article] [PubMed] [Google Scholar]
  • 83.Mboera LEG, Senkoro KP, Rumisha SF, Mayala BK, Shayo EH, Mlozi MRS. Plasmodium falciparum and helminth coinfections among schoolchildren in relation to agro-ecosystems in Mvomero District. Tanzania Acta Tropica. 2011;120(1):95–102. 10.1016/j.actatropica.2011.06.007 [DOI] [PubMed] [Google Scholar]
  • 84.Ajayi IO, Afonne C, Dada-Adegbola H, and Falade CO. Prevalence of Asymptomatic Malaria and Intestinal Helminthiasis Co-infection among Children Living in Selected Rural Communities in Ibadan Nigeria. American Journal of Epidemiology and Infectious Disease. 2015; 3(1): 15–20. 10.12691/ajeid-3-1-3 [DOI] [Google Scholar]
  • 85.Lyke KE, Dicko A, Dabo A, Sangare L, Kone A, Coulibaly D, et al. Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. The American journal of tropical medicine and hygiene 2005;73(6):1124–30. . [PMC free article] [PubMed] [Google Scholar]
  • 86.Ojo OE, Adebayo AS, Awobode HO, Nguewa P, Anumudu CI. Schistosoma haematobium and Plasmodium falciparum co-infection in Nigeria 2001–2018: A systematic review and meta-analysis. Scientific African. 2019;6:e00186. 10.1016/j.sciaf.2019.e00186 [DOI] [Google Scholar]
  • 87.Winkler S, Willheim M, Baier K, Schmid D, Aichelburg A, Graninger W, et al. Reciprocal regulation of Th1- and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria. Infect Immun. 1998;66(12):6040–4. Epub 1998/11/24. 10.1128/IAI.66.12.6040-6044.1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Pullan RL, Kabatereine NB, Bukirwa H, Staedke SG, Brooker S. Heterogeneities and consequences of Plasmodium species and hookworm coinfection: a population based study in Uganda. J Infect Dis 2011;203(3):406–17. Epub 2010/12/27. 10.1093/infdis/jiq063 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Haldar K, Mohandas N. Malaria, erythrocytic infection, and anemia. Hematology Am Soc Hematol Educ Program. 2009:87–93. Epub 2009/12/17. 10.1182/asheducation-2009.1.87 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0009138.r001

Decision Letter 0

Kristien Verdonck, Jessica K Fairley

1 Dec 2020

Dear Dr Afolabi,

Thank you very much for submitting your manuscript "Malaria and helminth co-infections in children living in low- and middle-income countries: a systematic review with meta-analysis" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.  

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. 

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Jessica K Fairley, MD, MPH

Associate Editor

PLOS Neglected Tropical Diseases

Kristien Verdonck

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: -The objectives of the study are clearly articulated.

-The study design is appropriate to address the stated objectives.

-The population is clearly described and appropriate for the hypothesis.

-The sample size has has added to the body of knowledge byt further studies are recommended.

-Correct statistical analysis were used to support conclusions.

-Are there no concerns about ethical or regulatory requirements

Reviewer #2: Abstract

Background

Line # 159-162

The authors need to describe the study objective clearly. It is a mixed of objective and utility of this review.

Methodology/Principal Findings

1) Line # 44-47 Information provided is not yet clear enough

Please, rephrase these sentences. . The authors chose a random model due to a substantial heterogeneity among studies (i.e. I2 test more than?? %). Please, provide a relevant ref (e.g. Higgins et al 2019. Cochrane Handbook for Systematic Reviews of Interventions version 6 )

2) To be more informative, please provide I 2 values (after OR and its 95%I) for important outcomes.

3) Line # 58……………..It will be better to describe “A subset of 16 studies …..”

Text

Eligibility Criteria

1) Line # 172-76

Because of observational studies, PECO format should be more applicable.

It will be better to present the inclusion criteria addressing each acronym

For example,

Participants ( P): children aged 1-16 years living in LMIC,

2) Line # 177

Adults or pregnant women were excluded. To be more informative, please give justifications in the light of immune status or pathophysiology.

3) Line # 204-205

It will be better to provide kappa statistic.

Data Analysis

Line # 230

If adjusted OR was not available in an included study, how would you treat such study?

The authors did not provide how they had estimated a pooled prevalence. (On line # 293, the authors provided the results of pooled prevalence. If so, the method of pooling prevalence should have been described in the method section). For more details, please, see a ref (Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72(1):39). This paper addressed tests of significance on the pooled proportion which typically rely on normal probabilities. It also, address Freeman-Tukey double arcsine transformation (this ref paper is aimed to address metaprop package in STATA. But, it is applicable for methodological aspect of pooled prevalence, regardless of software used.)

Reviewer #3: The objectives of the study are clearly articulated with a clear testable hypothesis.

The study design is appropriate to address the research question

The population description is not appropriate for the hypothesis being tested, since the pathogens study or reviewed are not limited to the LMIC, rather to endemic regions. The age groups are not well define and seems to be limited to infants without explaining the rationnal to exclude adults or not.

The title of the review including LMIC, but there is no rationale under this specification. Would co-infection of helminth and malaria differ in non-LMIC? One could simply consider in endemic areas

The keys word includes paediatrics population, which is too specific. Better consider pre- and school children

The sample size calculation is not applicable in the review.

The statistical analysis is appropriate to support the conclusion.

The ethical issue is not applicable. However the review is registerred.

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: The analysis presented match the analysis plan and the results are clearly and completely presented.

However the data in Figure 2 presents P-Schisto first and P-STH afterwards which in the reverse to the data presented in the Abstract and the main text. I recommend reversing the data presentin Figure 2 to match the flow of the text.

The age range(s) in Table 1 for manuscripts 9, 10, 11, 23 and 44 are unclear.

Reviewer #2: The current presentation is not yet smooth. It will be better to improve the flow of presentation.

Having mentioned above, it will be better to provide I2 values.

Reviewer #3: The analysis presented match the analysis plan

In general the results are clearly presented, howver, two sub title overlap. line 334 Anaemia in Plasmodium- helminth co-infections" and line 365: Anaemia induced by malaria-helminth co-infection" . More distinction are needed.

The other reviews on co-infection should be reviewed and taking in consideration to avoid the redundant since some facts are known already

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: The conclusions are supported by the data presented.

The limitations of the analysis (suitable published manuscripts from LMIC) are clearly described.

The authors discuss how these data can be helpful to advance our understanding of the topic under study and the need fro further studies and analysis.

The public health relevance of immune-regulation should be further addressed and potentially its long-term implications if programs continue to make progress towards control/elimination.

Reviewer #2: It is difficult to catch the salient points. It will be better to present with the use of subheadings, including study limitations.

Reviewer #3: The conclusion are clear and supported by data presented. The limitation are described, as well as public health relevance.

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: Minor Revision to address suggestions to Figure 2 and Table 1 and expand the discussion on immune regulation.

Reviewer #2: (No Response)

Reviewer #3: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: This is a well researched and well presented paper.

The topic is highly significant as the global burden of STH and Schito reduce and the complicated interaction with malaria, anaemia and possibly other infections such as Covid-19 are so little understood.

Reviewer #2: It is fine.

Reviewer #3: The review entitled " Malaria and helminth co-infections in children living in low- and middle-income

countries: a systematic review with meta-analysis "undertake, by Dr. Affolabi et al, is useful and mark a new step regarding the rationale research question of co-infection of malaria and helminths in term of susceptibility and immune responses. However some points need to be addressed ahead.

The title of the review including LMIC, but there is no rationale under this specification. Would co-infection of helminth and malaria differ non-LMIC? One could simply consider in endemic areas

The keys word includes paediatrics population, which is too specific. Better consider pre- and school children

On line 85, the egg detection methods are too limited. Please elaborate a bite more

All studies announced are not refferenced

Two sub title overlap. line 334 Anaemia in Plasmodium- helminth co-infections" and line 365: Anaemia induced by malaria-helminth co-infection"

Other reviews on co-infection should be reviewed to avoid the redundant since some facts are known already

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plosntds/s/submission-guidelines#loc-materials-and-methods

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0009138.r003

Decision Letter 1

Kristien Verdonck, Jessica K Fairley

13 Jan 2021

Dear Dr Afolabi,

We are pleased to inform you that your manuscript 'Malaria and helminth co-infections in children living in endemic countries: a systematic review with meta-analysis' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Jessica K Fairley, MD, MPH

Associate Editor

PLOS Neglected Tropical Diseases

Kristien Verdonck

Deputy Editor

PLOS Neglected Tropical Diseases

***********************************************************

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0009138.r004

Acceptance letter

Kristien Verdonck, Jessica K Fairley

4 Feb 2021

Dear Dr Afolabi,

We are delighted to inform you that your manuscript, "Malaria and helminth co-infections in children living in endemic countries: a systematic review with meta-analysis," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Forest plot showing pooled prevalence of malaria-helminth co-infection by geographic region.

    (DOCX)

    S2 Fig

    a-b-c: Forest plot showing sub-group analysis of summary estimates of prevalence of P.falciparum-A. lumbricoides co-infection, forest plot showing sub-group analysis of summary estimates of prevalence of P.falciparum-hookworm co-infection, forest plot showing sub-group analysis of summary estimates of prevalence of P.falciparum-T.trichuria co-infection.

    (DOCX)

    S3 Fig

    a-b: Forest plot showing sub-group analysis of prevalence of Plasmodium-S. haematobium co-infection in children in LMIC, forest plot showing sub-group analysis of prevalence of Plasmodium-S.mansoni co-infection in children in LMIC.

    (DOCX)

    S4 Fig. Forest plot showing the risk of asymptomatic/uncomplicated or severe P. falciparum infection in children co-infected with STH compared with children who did not have STH infection when adjusted for geographic location of the study participants.

    (DOCX)

    S5 Fig. Forest plot showing the risk of asymptomatic/uncomplicated or severe P. falciparum infection in children co-infected with STH compared with children who did not have STH infection when adjusted for age, gender, socio-economic status and nutrition status of the children.

    (DOCX)

    S1 File. Study protocol including the search strategy.

    (PDF)

    Attachment

    Submitted filename: Response to reviewers.doc

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES